Brown adipose tissue: A promising target to combat obesity

Drug News and Perspectives

Volumn 23, Issue 7, 2010, Pages 409-417

  Vernochet, Cecile ^a   McDonald, Meghan E ^a   Farmer, Stephen R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; NICOTINAMIDE; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PR DOMAIN ZINC FINGER PROTEIN 16; QUINOXALINE; RECEPTOR INTERACTING PROTEIN 140; RESVERATROL; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 6; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ANTIOBESITY AGENT; DNA BINDING PROTEIN; PRDM16 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOGENESIS; BROWN ADIPOSE TISSUE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL FUNCTION; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; ENERGY CONSERVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; INSULIN SENSITIVITY; MUSCLE CELL; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WHITE ADIPOSE TISSUE; ANIMAL; DRUG DELIVERY SYSTEM; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY;

ADIPOCYTES, BROWN; ADIPOSE TISSUE, BROWN; ANIMALS; ANTI-OBESITY AGENTS; DNA-BINDING PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; METABOLIC SYNDROME X; OBESITY; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 79952115255     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2010.23.7.1487083     Document Type: Review

References (114)

1. Alberti, K.G. The costs of non-insulin-dependent diabetes mellitus. Diabet Med 1997, 14(1): 7-9.
2. Hogan, P., Dall, T., Nikolov, P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003, 26(3): 917-32.
3. Cinti, S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids 2005, 73(1): 9-15.
4. Cannon, B., Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004, 84(1): 277-359.
5. Nedergaard, J., Bengtsson, T., Cannon, B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007, 293(2): E444-52.
6. Virtanen, K.A., Lidell, M.E., Orava, J. et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360(15): 1518-25.
7. Cypess, A.M., Lehman, S., Williams, G. et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009, 360(15): 1509-17.
8. van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M. et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009, 360(15): 1500-8.
9. Zingaretti, M.C., Crosta, F., Vitali, A. et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 2009, 23(9): 3113-20.
10. Farmer, S.R. Molecular determinants of brown adipocyte formation and function. Genes Dev 2008, 22(10): 1269-75.
11. Farmer, S.R. Obesity: Be cool, lose weight. Nature 2009, 458(7240): 839-40.
12. Fruhbeck, G., Becerril, S., Sainz, N., Garrastachu, P., Garcia-Velloso, M.J. BAT: a new target for human obesity? Trends Pharmacol Sci 2009, 30(8): 387-96.
13. Cypess, A.M., Kahn, C.R. Brown fat as a therapy for obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 2010, 17(2): 143-9.
14. Buckingham, M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 2006, 16(5): 525-32.
15. Timmons, J.A., Wennmalm, K., Larsson, O. et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A 2007, 104(11): 4401-6.
16. Atit, R., Sgaier, S.K., Mohamed, O.A. et al. Beta-catenin activation is necessary and sufficient to specify the dorsal dermal fate in the mouse. Dev Biol 2006, 296(1): 164-76.
17. Seale, P., Bjork, B., Yang, W. et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454(7207): 961-7.
18. Rodeheffer, M.S., Birsoy, K., Friedman, J.M. Identification of white adipocyte progenitor cells in vivo. Cell 2008, 135(2): 240-9.
19. Tang, W., Zeve, D., Suh, J.M. et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322(5901): 583-6.
20. Allt, G., Lawrenson, J.G. Pericytes: cell biology and pathology. Cells Tissues Organs 2001, 169(1): 1-11.
21. Billon, N., Iannarelli, P., Monteiro, M.C. et al. The generation of adipocytes by the neural crest. Development 2007, 134(12): 2283-92.
22. Gupta, R.K., Arany, Z., Seale, P. et al. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464(7288): 619-23.
23. Farmer, S.R. Transcriptional control of adipocyte formation. Cell Metab 2006, 4(4): 263-73.
24. Lefterova, M.I., Lazar, M.A. New developments in adipogenesis. Trends Endocrinol Metab 2009, 20(3): 107-14.
25. Rosen, E.D., Sarraf, P., Troy, A.E. et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999, 4(4): 611-7.
26. Linhart, H.G., Ishimura-Oka, K., DeMayo, F. et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci U S A 2001, 98(22): 12532-7.
27. Tontonoz, P., Spiegelman, B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008, 77: 289-312.
28. Seale, P., Kajimura, S., Yang, W. et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 2007, 6(1): 38-54.
29. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman, B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92: 829-39.
30. Handschin, C., Spiegelman, B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006, 27(7): 728-35.
31. Lin, J., Wu, P.H., Tarr, P.T. et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119(1): 121-35.
32. Uldry, M., Yang, W., St-Pierre, J., Lin, J., Seale, P., Spiegelman, B.M. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 2006, 3(5): 333-41.
33. Davis, C.A., Haberland, M., Arnold, M.A. et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol 2006, 26(7): 2626-36.
34. Kinameri, E., Inoue, T., Aruga, J., Imayoshi, I., Kageyama, R., Shimogori, T., Moore, A.W. Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. PLoS One 2008, 3(12): e3859.
35. Bikoff, E.K., Morgan, M.A., Robertson, E.J. An expanding job description for Blimp-1/PRDM1. Curr Opin Genet Dev 2009, 19(4): 379-85.
36. Mucenski, M.L., Taylor, B.A., Ihle, J.N., Hartley, J.W., Morse, H.C., 3rd, Jenkins, N.A., Copeland, N.G. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988, 8(1): 301-8.
37. Nishikawa, N., Toyota, M., Suzuki, H. et al. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res 2007, 67(20): 9649-57.
38. Pasqualucci, L., Compagno, M., Houldsworth, J. et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006, 203(2): 311-7.
39. Reid, A.G., Nacheva, E.P. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia 2004, 18(1): 178-80.
40. Tam, W., Gomez, M., Chadburn, A., Lee, J.W., Chan, W.C., Knowles, D.M. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 2006, 107(10): 4090-100.
41. Jenuwein, T. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell Biol 2001, 11(6): 266-73.
42. Mochizuki, N., Shimizu, S., Nagasawa, T., Tanaka, H., Taniwaki, M., Yokota, J., Morishita, K. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 2000, 96(9): 3209-14.
43. Kajimura, S., Seale, P., Tomaru, T. et al. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev 2008, 22(10): 1397-409.
44. Murholm, M., Dixen, K., Qvortrup, K. et al. Dynamic regulation of genes involved in mitochondrial DNA replication and transcription during mouse brown fat cell differentiation and recruitment. PLoS One 2009, 4(12): e8458.
45. Kajimura, S., Seale, P., Kubota, K., Lunsford, E., Frangioni, J.V., Gygi, S.P., Spiegelman, B.M. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009, 460(7259): 1154-8.
46. Hansen, J.B., Jorgensen, C., Petersen, R.K. et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A 2004, 101(12): 4112-7.
47. Scime, A., Grenier, G., Huh, M.S., Gillespie, M.A., Bevilacqua, L., Harper, M.E., Rudnicki, M.A. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab 2005, 2(5): 283-95.
48. Tseng, Y.H., Butte, A.J., Kokkotou, E. et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol 2005, 7(6): 601-11.
49. Deponti, D., Francois, S., Baesso, S. et al. Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J Cell Biol 2007, 179(2): 305-19.
50. Leonardsson, G., Steel, J.H., Christian, M. et al. Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A 2004, 101(22): 8437-42.
51. Christian, M., Kiskinis, E., Debevec, D., Leonardsson, G., White, R., Parker, M.G. RIP140-targeted repression of gene expression in adipocytes. Mol Cell Biol 2005, 25(21): 9383-91.
52. Powelka, A.M., Seth, A., Virbasius, J.V. et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 2006, 116(1): 125-36.
53. Yamaguchi, A., Komori, T., Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000, 21(4): 393-411.
54. Yang, Y. Skeletal morphogenesis during embryonic development. Crit Rev Eukaryot Gene Expr 2009, 19(3): 197-218.
55. Roca, C., Adams, R.H. Regulation of vascular morphogenesis by Notch signaling. Genes Dev 2007, 21(20): 2511-24.
56. Morrow, D., Guha, S., Sweeney, C. et al. Notch and vascular smooth muscle cell phenotype. Circ Res 2008, 103(12): 1370-82.
57. Bowers, R.R., Lane, M.D. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 2007, 6(4): 385-9.
58. Cossu, G., Borello, U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 1999, 18(24): 6867-72.
59. Bailey, P., Holowacz, T., Lassar, A.B. The origin of skeletal muscle stem cells in the embryo and the adult. Curr Opin Cell Biol 2001, 13(6): 679-89.
60. Buckingham, M. How the community effect orchestrates muscle differentiation. Bioessays 2003, 25(1): 13-6.
61. Tseng, Y.H., Kokkotou, E., Schulz, T.J. et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008, 454(7207): 1000-4.
62. Gesta, S., Tseng, Y.H., Kahn, C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131(2): 242-56.
63. Carey, V.J., Walters, E.E., Colditz, G.A. et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997, 145(7): 614-9.
64. Misra, A., Garg, A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 2003, 82(2): 129-46.
65. Nicklas, B.J., Cesari, M., Penninx, B.W. et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 2006, 54(3): 413-20.
66. Misra, A., Garg, A., Abate, N., Peshock, R.M., Stray-Gundersen, J., Grundy, S.M. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 1997, 5(2): 93-9.
67. Snijder, M.B., Dekker, J.M., Visser, M. et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003, 77(5): 1192-7.
68. Snijder, M.B., Dekker, J.M., Visser, M. et al. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res 2003, 11(1): 104-11.
69. Wilson-Fritch, L., Nicoloro, S., Chouinard, M. et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 2004, 114(9): 1281-9.
70. Vernochet, C., Peres, S.B., Davis, K.E. et al. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol 2009, 29(17): 4714-28.
71. Petrovic, N., Walden, T.B., Shabalina, I.G., Timmons, J.A., Cannon, B., Nedergaard, J. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 2010, 285(10): 7153-64.
72. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H., Evans, R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93(2): 229-40.
73. Smith, S.R., De Jonge, L., Volaufova, J., Li, Y., Xie, H., Bray, G.A. Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. Metabolism 2005, 54(1): 24-32.
74. Laplante, M., Festuccia, W.T., Soucy, G., Gelinas, Y., Lalonde, J., Berger, J.P., Deshaies, Y. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes 2006, 55(10): 2771-8.
75. Laplante, M., Festuccia, W.T., Soucy, G. et al. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat. Am J Physiol Regul Integr Comp Physiol 2009, 296(1): R57-66.
76. Festuccia, W.T., Blanchard, P.G., Turcotte, V. et al. The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake. Am J Physiol Regul Integr Comp Physiol 2009, 296(5): R1327-35.
77. Wilson-Fritch, L., Burkart, A., Bell, G. et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 2003, 23(3): 1085-94.
78. Rizos, C.V., Elisaf, M.S., Mikhailidis, D.P., Liberopoulos, E.N. How safe is the use of thiazolidinediones in clinical practice? Expert Opin Drug Saf 2009, 8(1): 15-32.
79. Chinnadurai, G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 2009, 69(3): 731-4.
80. Chinnadurai, G. Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol 2007, 39(9): 1593-607.
81. Vernochet, C., Davis, K.E., Scherer, P.E., Farmer, S.R. Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes. Endocrinology 2010, 151(2): 586-94.
82. Christian, M., White, R., Parker, M.G. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol Metab 2006, 17(6): 243-50.
83. White, R., Morganstein, D., Christian, M., Seth, A., Herzog, B., Parker, M.G. Role of RIP140 in metabolic tissues: connections to disease. FEBS Lett 2008, 582(1): 39-45.
84. Yu, J., Auwerx, J. The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci 2009, 1173 Suppl 1: E10-9.
85. Imai, S., Guarente, L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010, 31(5): 212-20.
86. Bordone, L., Guarente, L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005, 6(4): 298-305.
87. Bordone, L., Cohen, D., Robinson, A. et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007, 6(6): 759-67.
88. Fullerton, M.D., Steinberg, G.R. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 2010, 59(3): 551-3.
89. Nayagam, V.M., Wang, X., Tan, Y.C. et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen 2006, 11(8): 959-67.
90. Milne, J.C., Lambert, P.D., Schenk, S. et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450(7170): 712-6.
91. Neugebauer, R.C., Sippl, W., Jung, M. Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Curr Pharm Des 2008, 14(6): 562-73.
92. Schemies, J., Uciechowska, U., Sippl, W., Jung, M. NAD(+)-dependent histone deacetylases (sirtuins) as novel therapeutic targets. Med Res Rev 2009.
93. Guarente, L., Picard, F. Calorie restriction - the SIR2 connection. Cell 2005, 120(4): 473-82.
94. Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434(7029): 113-8.
95. Picard, F., Kurtev, M., Chung, N. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429(6993): 771-6.
96. Canto, C., Jiang, L.Q., Deshmukh, A.S. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010, 11(3): 213-9.
97. Vaquero, A., Scher, M.B., Lee, D.H. et al. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev 2006, 20(10): 1256-61.
98. Jing, E., Gesta, S., Kahn, C.R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 2007, 6(2): 105-14.
99. Shi, T., Wang, F., Stieren, E., Tong, Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005, 280(14): 13560-7.
100. Schwer, B., Bunkenborg, J., Verdin, R.O., Andersen, J.S., Verdin, E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A 2006, 103(27): 10224-9.
101. Hallows, W.C., Lee, S., Denu, J.M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 2006, 103(27): 10230-5.
102. Capel, F., Viguerie, N., Vega, N. et al. Contribution of energy restriction and macronutrient composition to changes in adipose tissue gene expression during dietary weight-loss programs in obese women. J Clin Endocrinol Metab 2008, 93(11): 4315-22.
103. Yang, H., Yang, T., Baur, J.A. et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007, 130(6): 1095-107.
104. Haigis, M.C., Mostoslavsky, R., Haigis, K.M. et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126(5): 941-54.
105. Zhong, L., D'Urso, A., Toiber, D. et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140(2): 280-93.
106. Nerlov, C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007, 17(7): 318-24.
107. Nerlov, C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008, 20(2): 180-5.
108. Carmona, M.C., Hondares, E., Rodriguez de la Concepcion, M.L. et al. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta. Biochem J 2005, 389(Pt 1): 47-56.
109. Karamanlidis, G., Karamitri, A., Docherty, K., Hazlerigg, D.G., Lomax, M.A. C/EBPbeta reprograms white 3T3-L1 preadipocytes to a Brown adipocyte pattern of gene expression. J Biol Chem 2007, 282(34): 24660-9.
110. Uhrich, K.E., Cannizzaro, S.M., Langer, R.S., Shakesheff, K.M. Polymeric systems for controlled drug release. Chem Rev 1999, 99(11): 3181-98.
111. Kimura, Y., Inamoto, T., Tabata, Y. Adipose tissue formation in collagen scaffolds with different biodegradabilities. J Biomater Sci Polym Ed 2010, 21(4): 463-76.
112. Tran, T.T., Kahn, C.R. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol 2010, 6(4): 195-213.
113. Kimura, Y., Tsuji, W., Yamashiro, H., Toi, M., Inamoto, T., Tabata, Y. In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. J Tissue Eng Regen Med 2010, 4(1): 55-61.
114. Almind, K., Manieri, M., Sivitz, W.I., Cinti, S., Kahn, C.R. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci U S A 2007, 104(7): 2366-71.